Signal Detection for Cardiovascular Adverse Events of DPP-4 Inhibitors Using the Korea Adverse Event Reporting System Database, 2008–2016

PURPOSE: Cardiovascular adverse events (AEs) after use of dipeptidyl peptidase-4 (DPP4) inhibitors have been reported and suspected since the launch of DPP-4 inhibitors in 2006. However, few studies have investigated the association between cardiovascular AEs and DPP-4 inhibitors. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Hyemin, Lee, Ji-Ho, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342716/
https://www.ncbi.nlm.nih.gov/pubmed/30666842
http://dx.doi.org/10.3349/ymj.2019.60.2.200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342716/
https://www.ncbi.nlm.nih.gov/pubmed/30666842
http://dx.doi.org/10.3349/ymj.2019.60.2.200

Ejemplares similares